In trauma patients with significant bleeding and those with traumatic brain injury (TBI), tranexamic acid (TXA) has been scientifically tested through randomised, double-blind, placebo-controlled trials and shown to reduce mortality in both extracranial and intracranial bleeding

Find out more about this research below